01 / prediction

19 Jul 2017

The CRISPR capability is just another bullet in the holster that can be fired, but we are narrowing that neurotypical range in lots and lots of different directions, whether it’s how we employ people, what kinds of options we put out there for people to have their aberrant thinking recognized and taken advantage of, to the ways we medicate and control people. And I think CRISPR—it actually will be exceedingly difficult to be able to pick many of these capabilities out, in part because they’re multigene.

“The CRISPR capability is just another bullet in the holster that can be fired, but we are narrowing that neurotypical range in lots and lots of different directions, whether it’s how we employ people, what kinds of options we put out there for people to have their aberrant thinking recognized and taken advantage of, to the ways we medicate and control people. And I think CRISPR—it actually will be exceedingly difficult to be able to pick many of these capabilities out, in part because they’re multigene.”

Speaker: Atul Gawande
Episode: Atul Gawande on Priorities, Big and Small
Publisher: Conversations with Tyler

02 / prediction

19 Jul 2017

The way to think about it, though, is that we have a certain speed with which we have accelerated passage through the FDA.

“The way to think about it, though, is that we have a certain speed with which we have accelerated passage through the FDA.”

Speaker: Atul Gawande
Episode: Atul Gawande on Priorities, Big and Small
Publisher: Conversations with Tyler

What Atul said.

The way to think about it, though, is that we have a certain speed with which we have accelerated passage through the FDA.